Login
Login
切换导航
Home
Articles
Journals
Books
News
About
Submit
Home
Journal
Articles
Journals A-Z
Browse Subjects
Biomedical & Life Sci.
Business & Economics
Chemistry & Materials Sci.
Computer Sci. & Commun.
Earth & Environmental Sci.
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sci. & Humanities
Browse Subjects
Biomedical & Life Sciences
Business & Economics
Chemistry & Materials Science
Computer Science & Communications
Earth & Environmental Sciences
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sciences & Humanities
Publish with us
Paper Submission
Information for Authors
Peer-Review Resources
Open Special Issues
Open Access Statement
Frequently Asked Questions
Publish with us
Paper Submission
Information for Authors
Peer-Review Resources
Open Special Issues
Open Access Statement
Frequently Asked Questions
Follow SCIRP
Contact us
customer@scirp.org
+86 18163351462(WhatsApp)
1655362766
Paper Publishing WeChat
Complete Matching
Editorial Board
Show/Hide Options
Show/Hide Options
All
Title
Abstract
Keywords
DOI
Author
Journal
Affiliation
ISSN
Subject
Organ Preservation in Bilharzial Bladder Cancer in Egypt: Single Institutional Experience
(Articles)
Hamza Abbas
,
Mohamed Abdel Aboziada
,
Mostafa Elsayed Abdalwanis
,
Mohamed Abdallah El-Gmal
,
Ahmed Mokhtar
,
Mohamed Ahmed Abo-Almagd
,
Farouk Morad Amr
,
Ashraf Elyamany
Journal of Cancer Therapy
Vol.3 No.1
,February 17, 2012
DOI:
10.4236/jct.2012.31008
4,333
Downloads
7,328
Views
Citations
Advanced Breast Angiosarcoma Completely Responding to Chemotherapy
(Articles)
Zhiguo Luo
,
Qian Wang
,
Wei Peng
,
Jianhua Chang
,
Xichun Hu
,
Xiaonan Hong
Journal of Cancer Therapy
Vol.4 No.4
,May 31, 2013
DOI:
10.4236/jct.2013.44092
4,184
Downloads
6,140
Views
Citations
Concomitant Chemoradiation Using Gemcitabine in Locally Advanced Hepatocellular Carcinoma
(Articles)
Mohamed-Alaa-Eldeen H. Mohamed
Journal of Cancer Therapy
Vol.9 No.12
,December 29, 2018
DOI:
10.4236/jct.2018.912084
880
Downloads
1,872
Views
Citations
Simultaneous Dual Selective Targeted Delivery of Two Covalent Gemcitabine Immunochemotherapeutics and Complementary Anti-Neoplastic Potency of [Se]-Methylselenocysteine
(Articles)
C. P. Coyne
,
Toni Jones
,
Ryan Bear
Journal of Cancer Therapy
Vol.6 No.1
,January 16, 2015
DOI:
10.4236/jct.2015.61009
3,396
Downloads
4,175
Views
Citations
A Pilot Study of Gemcitabine and Epirubicin Combination Chemotherapy as a Salvage Regimen for Recurrent Platinum Resistant and/or Refractory Epithelial Ovarian Cancer
(Articles)
Abd El Halim Abu-Hamar
Journal of Cancer Therapy
Vol.2 No.4
,October 12, 2011
DOI:
10.4236/jct.2011.24066
4,930
Downloads
8,330
Views
Citations
Comparison of 4-Weekly vs 3-Weekly Gemcitabine as Adjuvant Chemotherapy Following Curative Resection for Biliary Tract Cancer: A Prospective Randomized Controlled Trial
(Articles)
Shogo Kobayashi
,
Atsushi Miyamoto
,
Junzo Shimizu
,
Masaki Kashiwazaki
,
Yutaka Takeda
,
Shigeyuki Ueshima
,
Yongkook Kim
,
Toru Kitagawa
,
Keizo Dono
,
Masaki Mori
,
Yuichiro Doki
,
Hiroaki Nagano
Journal of Cancer Therapy
Vol.2 No.5
,December 31, 2011
DOI:
10.4236/jct.2011.25095
3,971
Downloads
6,814
Views
Citations
Gemcitabine Inhibits Murine Head and Neck Squamous Cell Carcinoma Growth via Proteasome-Dependent Degradation of Chk1 Leading to Cell Cycle Arrest and Apoptosis
(Articles)
Anren Song
,
Jean Wu
,
Emily Whitaker
,
Nadarajah Vigneswaran
Journal of Cancer Therapy
Vol.3 No.5
,October 18, 2012
DOI:
10.4236/jct.2012.35072
3,448
Downloads
5,392
Views
Citations
Triplet chemotherapy with paclitaxel, gemcitabine, and cisplatin as second-line therapy for advanced urothelial carcinoma
(Articles)
Hideki Takeshita
,
Koji Chiba
,
Sachi Kitayama
,
Shingo Moriyama
,
Rika Omura
,
Akira Noro
Modern Chemotherapy
Vol.2 No.1
,January 30, 2013
DOI:
10.4236/mc.2013.21001
4,032
Downloads
10,604
Views
Citations
Practical Use of Gemcitabine and Cisplatin Combination Therapy as First-Line Treatment for Japanese Patients with Advanced Biliary Tract Cancer
(Articles)
Hisato Kawakami
,
Isamu Okamoto
,
Wataru Okamoto
,
Masayuki Takeda
,
Shinya Ueda
,
Toshihiro Kudo
,
Shin-ichi Nishina
,
Yasuhito Fujisaka
,
Masaki Miyazaki
,
Junji Tsurutani
,
Takayasu Kurata
,
Kazuhiko Nakagawa
Journal of Cancer Therapy
Vol.4 No.6
,July 17, 2013
DOI:
10.4236/jct.2013.46121
3,685
Downloads
5,349
Views
Citations
Chemotherapy (Gemcitabine plus Carboplatin versus Paclitaxel plus Carboplatin) in Elderly Patients with Non-Small Cell Lung Cancer
(Articles)
Takanori Ayabe
,
Masaki Tomita
,
Eiichi Chosa
,
Makoto Ikenoue
,
Yukie Shirasaki
,
Kunihide Nakamura
Journal of Cancer Therapy
Vol.5 No.3
,March 25, 2014
DOI:
10.4236/jct.2014.53035
2,834
Downloads
4,543
Views
Citations
Gemcitabine and Doxorubicin Combination Enhance the Cytotoxic Effect to Pancreatic Cancer Cells BxPC3 and PANC1 through UMP/CMP Kinase 1
(Articles)
Shuxian Chen
,
Xu Wang
,
Xianghui Ye
,
Jian Jin
Journal of Biosciences and Medicines
Vol.5 No.10
,October 27, 2017
DOI:
10.4236/jbm.2017.510007
1,069
Downloads
2,709
Views
Citations
Prolonged Infusion of Low Dose Gemcitabine in Advanced Pancreatic Carcinoma
(Articles)
Elsayed Mostafa Ali
,
Ahmed M. Maklad
,
Salah M. Khallaf
Journal of Cancer Therapy
Vol.11 No.7
,July 16, 2020
DOI:
10.4236/jct.2020.117035
445
Downloads
1,424
Views
Citations
Pemetrexed and Gemcitabine for Chemotherapy Refractory Colorectal Cancer—Results of a Phase II and Translational Research Study
(Articles)
Karen-Lise Garm Spindler
,
Niels Pallisgaard
,
Rikke Fredslund Andersen
,
John Ploen
,
Anders Jakobsen
Journal of Cancer Therapy
Vol.4 No.6B
,July 5, 2013
DOI:
10.4236/jct.2013.46A2006
3,667
Downloads
5,531
Views
Citations
This article belongs to the Special Issue on
Colorectal Cancer
Impact of ABO Blood Types on Survival after Pancreatectomy for Pancreatic Cancer
(Articles)
Tadashi Kayashima
,
Masafumi Nakamura
,
Kenoki Ohuchida
,
Syunichi Takahata
,
Kohei Nakata
,
Naoki Ikenaga
,
Lin Cui
,
Shingo Kozono
,
Kazuhiro Mizumoto
,
Masao Tanaka
Journal of Cancer Therapy
Vol.4 No.10A
,October 28, 2013
DOI:
10.4236/jct.2013.410A002
3,267
Downloads
5,549
Views
Citations
This article belongs to the Special Issue on
Pancreatic Cancer Research
Fixed Dose Rate versus Standard Dose Rate Infusion of Gemcitabine and Cisplatin in Advanced Stage Non-Small Cell Lung Cancer
(Articles)
Dina A. Salem
,
Dina R. Ibrahim
,
Ahmed Ezzat
,
Azza M. Adel
Journal of Cancer Therapy
Vol.6 No.1
,January 8, 2015
DOI:
10.4236/jct.2015.61007
4,198
Downloads
5,539
Views
Citations
In Vitro
Model Systems to Investigate Drug Resistance Mechanisms in Pancreatic Cancer Cells
(Articles)
Eric Romney
,
Vinay J. Nagaraj
Advances in Biological Chemistry
Vol.5 No.7
,December 30, 2015
DOI:
10.4236/abc.2015.57026
4,942
Downloads
5,933
Views
Citations
In Frail Elderly Patients, Low-Dose Gemcitabine over 6-Hour Infusion Is Equally Effective and Less Toxic Than the Standard Gemcitabine Protocol for Advanced Pancreatic Adenocarcinoma: A Randomized Phase II Trial
(Articles)
Salah Mabrouk Khallaf
,
Elsayed Mostafa Ali
,
Ahmed M. Maklad
,
Mohamed Medhat Samir
,
Anwar Tawfik Amin
,
Muhammad Abbas El-Masry
,
Mona M. Sayed
,
Dalia Osama
Journal of Cancer Therapy
Vol.11 No.3
,March 24, 2020
DOI:
10.4236/jct.2020.113011
569
Downloads
1,688
Views
Citations
Adjuvant Chemotherapy of Gemcitabine plus Carboplatin versus Paclitaxel plus Carboplatin in Patients with Resected Non-Small Cell Lung Cancer
(Articles)
Takanori Ayabe
,
Masaki Tomita
,
Kunihide Nakamura
Journal of Cancer Therapy
Vol.4 No.8A
,August 21, 2013
DOI:
10.4236/jct.2013.48A003
3,784
Downloads
5,869
Views
Citations
This article belongs to the Special Issue on
Advances in lung Cancer and Treatment Research
Synthesis of Gemcitabine-(C
4
-
amide
)-[anti-HER2/
neu
] Utilizing a UV-Photoactivated Gemcitabine Intermediate: Cytotoxic Anti-Neoplastic Activity against Chemotherapeutic-Resistant Mammary Adenocarcinoma SKBr-3
(Articles)
Cody P. Coyne
,
Toni Jones
,
Ryan Bear
Journal of Cancer Therapy
Vol.3 No.5A
,November 1, 2012
DOI:
10.4236/jct.2012.325089
6,027
Downloads
10,172
Views
Citations
This article belongs to the Special Issue on
Breast Cancer
Follow SCIRP
Contact us
customer@scirp.org
+86 18163351462(WhatsApp)
1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Home
Journals A-Z
Subject
Books
Sitemap
Contact Us
About SCIRP
Publication Fees
For Authors
Peer-Review Issues
Special Issues
News
Service
Manuscript Tracking System
Subscription
Translation & Proofreading
FAQ
Volume & Issue
Policies
Open Access
Publication Ethics
Preservation
Retraction
Privacy Policy
Copyright © 2006-2023 Scientific Research Publishing Inc. All Rights Reserved.
Top